These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16597671)

  • 1. The logistic transform for bounded outcome scores.
    Lesaffre E; Rizopoulos D; Tsonaka R
    Biostatistics; 2007 Jan; 8(1):72-85. PubMed ID: 16597671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power and sample size calculations for discrete bounded outcome scores.
    Tsonaka R; Rizopoulos D; Lesaffre E
    Stat Med; 2006 Dec; 25(24):4241-52. PubMed ID: 16947202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of treatment effect adjusting for treatment changes using the intensity score method: application to a large primary prevention study for coronary events (MEGA study).
    Tanaka Y; Matsuyama Y; Ohashi Y;
    Stat Med; 2008 May; 27(10):1718-33. PubMed ID: 17922525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of bootstrap methods for estimating sample size and analysing health-related quality of life outcomes.
    Walters SJ; Campbell MJ
    Stat Med; 2005 Apr; 24(7):1075-102. PubMed ID: 15570625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling and inference for an ordinal effect size measure.
    Ryu E; Agresti A
    Stat Med; 2008 May; 27(10):1703-17. PubMed ID: 17918752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research.
    Lu M; Lyden PD; Brott TG; Hamilton S; Broderick JP; Grotta JC
    J Neurosci Methods; 2005 Apr; 143(2):209-16. PubMed ID: 15814153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Logistic quantile regression for bounded outcomes.
    Bottai M; Cai B; McKeown RE
    Stat Med; 2010 Jan; 29(2):309-17. PubMed ID: 19941281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative logit models for ordinal data: a case study involving allergic rhinitis severity scores.
    Lunn DJ; Wakefield J; Racine-Poon A
    Stat Med; 2001 Aug; 20(15):2261-85. PubMed ID: 11468763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining dependent tests to compare the diagnostic accuracies--a non-parametric approach.
    Yang Y; Jin Z
    Stat Med; 2006 Apr; 25(7):1239-50. PubMed ID: 16158406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective analysis of clinical evaluation and self-assessment by patients after decompression surgery for degenerative lumbar canal stenosis.
    Haro H; Maekawa S; Hamada Y
    Spine J; 2008; 8(2):380-4. PubMed ID: 17433781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials.
    Sullivan LM; D'Agostino RB
    Stat Med; 2003 Apr; 22(8):1317-34. PubMed ID: 12687657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size and statistical power assessing the effect of interventions in the context of mixture distributions with detection limits.
    Chu H; Nie L; Cole SR
    Stat Med; 2006 Aug; 25(15):2647-57. PubMed ID: 16456897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
    Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH
    J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.
    Lesaffre E; Senn S
    Stat Med; 2003 Dec; 22(23):3583-96. PubMed ID: 14652862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline information in structural failure time estimators for the effect of observed treatment compliance.
    Loeys T; Goetghebeur E
    Stat Med; 2002 May; 21(9):1173-88. PubMed ID: 12111873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic differences in treatment effect estimates between propensity score methods and logistic regression.
    Martens EP; Pestman WR; de Boer A; Belitser SV; Klungel OH
    Int J Epidemiol; 2008 Oct; 37(5):1142-7. PubMed ID: 18453634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial.
    Lu M; Tilley BC;
    Stat Med; 2001 Jul; 20(13):1891-901. PubMed ID: 11427947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.